The interview also caught the eye of the aforementioned Professor Ellis ... The police will go mad." The first MK bombs went off on December 16, 1961. The rest is history.

Scorpion and Sub-Zero from "Mortal Kombat" are similar in many ways, but their powers differ greatly. Here's who we think is ...

Mortal Kombat 1 celebrates ... the Conflagrant Master fits Scorpion and his powers the most. Along with the burning pauldron, the entire skin is adorned with a fire theme, which suits Scorpion ...

I am going to be talking about this new ninja picture from the Mortal Kombat X Comics that is going around. I give my ...

A new study from the Koret School of Veterinary Medicine at Hebrew University has brought new insights into Florida spot keratopathy (FSK), an eye condition ... seeing little fire ants (LFA ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Feb. 1—MORGANTOWN — To accommodate the design of WVU Hospitals' forthcoming $233.5 million eye institute project, Morgantown City Council will consider a land swap that will relocate the road ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.